Pegylated Wortmannin and 17-Hydroxywortmannin Conjugates as Phosphoinositide 3-Kinase Inhibitors Active in Human Tumor Xenograft Models

Tianmin Zhu, Jianxin Gu, Ker Yu, Judy Lucas, Ping Cai, Russ Tsao, Yumin Gong, Fangbiao Li, Parimal R. Desai, Mark Ruppen,

Journal of Medicinal Chemistry · 2006 · 42 citations · 6 references

Concepts

Abstract

Phosphoinositide 3-kinase (PI3K) is an important target for cancer chemotherapy due to the deregulation of its signaling pathway in a wide spectrum of human tumors. Wortmannin and its analogues are potent PI3K inhibitors whose therapeutic use has been impeded by inherent defects such as instability and toxicity. Pegylation of wortmannin and 17-hydroxywortmannin gives rise to conjugates with improved properties, including a higher therapeutic index. Pegylated 17-hydroxywortmannin (8, PWT-458) has been selected for further development.

References

6